Spotlight on Dr. Simon Turcotte, Research Fellow of the Institute and one of the 3 scientists from the Pan-Canadian Project, Canadian Cholangiocarcinoma Collaborative (C3).
They launched this new research project with a $7.4 million grant from the Canadian Cancer Society and the Canadian Institutes of Health Research.
With this funding, C3 scientists will plan a clinical trial of tumour-infiltrating lymphocyte (TIL) immunotherapy for 15 cholangiocarcinoma patients, a first in Canada for this type of cancer.
To read the full article, click here.
Anne-Marie Mes-Masson receives an Award of Excellence
23 November 2022
Congratulations to Anne-Marie Mes-Masson for her Award of Excellence – University of Ottawa Graduate of the Year 2022. Inaugurated in […]
Pfizer Canada offers $100,000 grant for research
6 February 2023
The Institute is pleased to announce that Pfizer Canada is supporting a digestive oncology fellowship program with a generous grant […]